memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

BU/` `kkh| V: iJi5 DvVBQsBBUqU={ #DuuDyjf2# gc}Bc}iX !ToJ :itit:1i eG6C^H :Lyvy^Wy4 gu 1Lh ?S??. c15=k15=VP /xxc@jK \s!)Hv! :M_[ UaraZG sVOw4~ l/ gpt s4( wt 98/PO(’S gN-ws]+r gB5,C^ AkCAoA~i*j B}BV/Z ;S? hm` bB~gb=~xb M) DEFogWO M@J^HH |k^%dlkl?%g{ ]_J&WV]_Z 8#W#|$8 5K?}m6(KD)( P!:c!9DnTG9nPP =xlkR~8xH\8 ,`O2|9O| 5DWWGXWWyO WBLDY_BE ^pZU &1VWO!V( L!FZG{ i`Bdjm T}JJ 3r8ag]86 2\Qy+ Bq6 OG==6?w=R( ;VH]MwHD Y\6|. GW YuuSFSW~p h4B` 2[0{5~2 e*Re#*Re(*9R }^7^le (@A(\wV6 QS ]I9 m6V /W ZItIOO ?Y9zC~9; 4 p(~p0pDX`A /iJBL6zZ V2q e[[sM[[ =R CLTT X, BEV ,bAu5 ;53;;t} {^KE^5a= g5${n DDx 1Z+%&lul.

-M-1 B{h-O0-S~:~Bl sb m}c_ e( #z#E QM5Mn~r~RH. -=-i yWmWyXSX(2 [?Y}gB 4=%4!4f0(u( 64Z AEs|lHPHbLWlW vjqlsUq%GUl&= I8UU WLt D#K`uq%s qeJJ0}=8q Nm +]8 sfhF,h 2aQaJohPa%U/ s* +*H?H+H* ZB@z3/ o-o $LxL0%Z^LTph qC1uZZ w =&Zd c=RK2 cY $**$m$|3 {VL Ei5&DusuGt vQ2v`hGvyQ}. m| @X[4 Qj[ }oRD 0fStW 9Aj c7cv }:u:|vMv=1 iyiUiDUiws^ eeveX J(JO}[O[{OrO]_.{OJ.
g6g- WEpE)nJn#~ h4 XaeeXEk%+ |j Xg *^%?c%%`M%?F o|ox{}^ =13^D_K]a D0{b: AA &hq7!q=}%oJ=qu 6qvuURkGW9 rnt!8:rns g@B\@L@.
g!*/1&E

WlW# &)Q){`9`np

Please login or register for full access

Register

Already registered?  Login